“Titanium” license applies if you work in Business, Industry & Finance
If you work in industry e.g. you’re employed by a Pharma/Biotech company, work in finance e.g. fund management or work in a “for-profit” business then a minimum of a Titanium license is required.
Before you buy BSB access, please read this:
- All licenses are based on a named “designated user” basis. You are buying access just for the person whose name is on the email used to login to BSB. This access cannot be shared with others.
- No content can be shared by any means and all readers of BSB content are required to have their own individual login ID. This means you can’t print off a copy, email a PDF or upload it to your server or intranet for others to read.
- We expect people to purchase a multi-user license if you are in a leadership role or are working in a team or group where content or insights may be shared directly or indirectly. You’ll see the cost of a 3 person license in our pricing table, we’re happy to quote for 5 or more users. The more users, the greater the discount. As a condition of access we may require the purchase of a license for a minimum number of users.
All multi-user licenses typically have an administrator, who may or may not be one of the named designated users, and he/she is responsible for advising who should have access. We will, subject to reasonable use, transfer the access for a designated user should someone leave the company or be reassigned. The company in essence owns the license and is in control of who has access. Please note, all users in a multi-user license must be employees of the company or an affiliate, you cannot give access to consultants or anyone external to the company.
If you are considering a large group multi-user license, but are not sure whether BSB will meet your needs, then we can offer you an online tour where we answer questions and take you behind the BSB paywall. At our discretion, we can offer a trial period for a large group to evaluate our content, subject to limitations on access to back content. This is usually heavily restricted in any trial.
If you work in finance, please note we do not provide any compliance review, nor can you pay with so called “soft dollars”. If you want to pay by those means or have compliance concerns, then there are other data sources out there that will better meet your needs and BSB is probably not right for you.
If you work in communications, medical education, IR, PR, media, consulting or for a service provider such as a CRO, then you need to contact us first to discuss how you will use our content, and our permission is required for any purchase. If you go ahead and purchase without permission, then any refund we may provide at our discretion will be less any non-refundable credit card fees.
“Gold” license applies if you are in academia or work for a non-profit organization but this has to be your main job!
We do have academic researchers and medical oncologists from round the world as subscribers to BSB. Not everyone can get to every meeting (in the days when we could all travel), and even with virtual access, you still have to find the time.
The field is moving at such a fast pace that textbooks are out of date by the time they are written, particularly in immuno-oncology and large meetings can be overwhelming in terms of the breadth and depth of content.
If you are in academia or work for a non-profit organization then the discounted gold license applies.
Please note we reserve the right to verify the eligibility of anyone who wishes to subscribe at this level, and we do expect people to be upfront as to who they are.
Think about it like going to a scientific or medical conference. If you are in “industry” you typically expect to pay more for a meeting registration than if you are a researcher or someone in academia or a non-profit.
Please note the academic/medical/non-profit has to be your main employment, so if you are an MD employed in industry or finance who does the occasional clinic, you do not qualify for the gold rate.
Irrespective of the license level purchased, no post can be shared within a company/ organisation or with others without payment of an additional fee either in the form of a share license or a permissions fee for a reprint.
Important note – for those in Media, Med Ed, IR, Comms, PR, Consulting and Service Providers – permission is required!
If you work in communications, medical education, IR, PR, media, consulting or for a service provider such as a CRO, then you need to contact us first to discuss how you will use our content, and our permission is required for any purchase.
PR, IR & Comms: We have sadly been burnt by PR folk sharing our content widely, so if you work in communications, IR, PR or a related agency and would like access to our content, we now require the purchase of a multi-user license that will cover everyone in the company.
If a PR company facilitates an interview, as a matter of routine, they will receive a courtesy copy of the related post we write.
We also offer, at our sole discretion, the ability to purchase access to an individual post as a reprint. The cost depends on the nature of the post and the extent to which it will be shared.
Consulting, Service Providers & Med Ed: If you work in consulting, medical education or for a service provider such as a CRO, and would like to have access to our content either as a resource for projects, a specific engagement or for your own education or that of a team member e.g. come up to speed on an area, we will need to discuss and understand how you will use our content, how many people within the team or company will have access to it, and what might be shared with client(s) or others. It is unlikely that we will grant access just for one person, and we would expect the purchase of a multi-user license, a clear definition on the scope of use, and would need to assess what the risk of sharing with non BSB subs might be.
Media: We are flattered that some of our media colleagues would like to purchase BSB access to help them with their coverage of oncology new products and the conferences/meetings we attend. However, in the competitive media landscape that we live in, we really have no interest in having our story ideas, insights or content repurposed by other outlets, even with attribution, so this is not something we typically allow.
Any decision is made on a case by case basis and we reserve the right to decline any purchase at our sole discretion or to require as a condition of access the purchase of a license that covers all in a group, team or company.
Sign-up for News Alerts and Deals
If you would like to receive email alerts about the latest posts, special offers and any news from a conferences or meetings we attend that we may wish to share just with email list subscribers, please sign up below: